Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies

Chinese Medical Journal Pulmonary and Critical Care Medicine · Published 2025-06-01 · DOI 10.1016/j.pccm.2025.05.002

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.pccm.2025.05.002

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles